|Articles|August 4, 2004
Start-up Alimera Sciences receives funding for ophthalmic products
Series A financing worth $26.75 million will be used by Alimera Sciences Inc. for acquisition and continued development of the company's ophthalmic pharmaceutical pipeline, along with commercialization of the company's over-the-counter ophthalmic products.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement














































.png)


